Kyverna Therapeutics, Inc.

NasdaqGS:KYTX Stock Report

Market Cap: US$172.7m

Kyverna Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:KYTX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
12 Feb 24BuyUS$9,900,000Northpond Ventures, LLCCompany450,000US$22.00
12 Feb 24BuyUS$20,020,000Gilead Sciences, Inc.Company910,000US$22.00
12 Feb 24BuyUS$9,900,000Bain Capital Life Sciences Investors, LLCCompany450,000US$22.00
12 Feb 24BuyUS$5,568,992Vida Ventures Advisors, LLCCompany253,136US$22.00

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of KYTX?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders976,2552.26%
Public Companies4,126,1199.56%
General Public5,158,18211.9%
VC/PE Firms15,671,64436.3%
Institutions17,239,41239.9%

Dilution of Shares: KYTX only recently listed within the past 12 months

Top Shareholders

Top 25 shareholders own 80.75% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
10.5%
Vida Ventures Advisors, LLC
4,523,924US$18.1m0%11.23%
10.5%
Westlake Village BioPartners
4,523,924US$18.1m0%no data
9.56%
Gilead Sciences, Inc.
4,126,119US$16.5m0%no data
7.8%
Bain Capital Life Sciences Investors, LLC
3,368,370US$13.5m0%1.41%
7.54%
Northpond Ventures, LLC
3,255,426US$13.0m0%24.64%
5.32%
JP Morgan Asset Management
2,294,675US$9.2m15%no data
4.29%
Novo Holdings A/S
1,850,000US$7.4m5.71%0.01%
3.52%
BlackRock, Inc.
1,520,261US$6.1m4.58%no data
2.9%
Millennium Management LLC
1,253,556US$5.0m35.8%no data
2.33%
The Vanguard Group, Inc.
1,006,707US$4.0m-0.98%no data
2.16%
Franklin Resources, Inc.
931,861US$3.7m13.2%no data
2.13%
Deerfield Management Company, L.P. Series C
918,892US$3.7m-53.7%0.06%
2.11%
Insight Venture Management, LLC
912,915US$3.7m0%0.17%
1.46%
T. Rowe Price Group, Inc.
628,222US$2.5m-6.17%no data
1.42%
MBB Public Markets I LLC
614,477US$2.5m49.8%0.22%
1.04%
EcoR1 Capital, LLC
450,000US$1.8m0%0.06%
1.04%
Dominic Borie
449,210US$1.8m0%no data
1.03%
Geode Capital Management, LLC
443,312US$1.8m19%no data
0.94%
Peter Maag
407,541US$1.6m0%no data
0.76%
State Street Global Advisors, Inc.
326,192US$1.3m3.24%no data
0.58%
Sphera Funds Management Ltd
248,651US$994.6k5.35%0.17%
0.54%
Wellington Management Group LLP
235,123US$940.5k-67%no data
0.46%
Integral Health Asset Management, LLC
200,000US$800.0k0%0.1%
0.44%
E Fund Management Co., Ltd.
189,432US$757.7k0%no data
0.42%
Norges Bank Investment Management
180,593US$722.4k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 02:46
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Kyverna Therapeutics, Inc. is covered by 5 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Mitchell KapoorH.C. Wainwright & Co.
Lut Ming ChengJ.P. Morgan
Thomas SmithLeerink Partners LLC